Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in patients with myelodysplastic syndrome (MDS). Here, we define the clinical significance of these mutations in MDS and myelodysplastic/myeloproliferative neoplasms (MDS/MPN)....
المؤلفون الرئيسيون: | Malcovati, L, Papaemmanuil, E, Bowen, D, Boultwood, J, Della Porta, MG, Pascutto, C, Travaglino, E, Groves, M, Godfrey, A, Ambaglio, I, Gallì, A, Vià, D, Conte, S, Tauro, S, Keenan, N, Hyslop, A, Hinton, J, Mudie, L, Wainscoat, J, Futreal, P, Stratton, MR, Campbell, P, Hellström-Lindberg, E, Cazzola, M |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2011
|
مواد مشابهة
-
Myelodysplastic/myeloproliferative disorders
حسب: Luca Malcovati, وآخرون
منشور في: (2008-01-01) -
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
حسب: Luca Malcovati, وآخرون
منشور في: (2014-11-01) -
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
حسب: Mario Cazzola
منشور في: (2011-03-01) -
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool
حسب: Matteo G. Della Porta, وآخرون
منشور في: (2012-04-01) -
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
حسب: Pellagatti, A, وآخرون
منشور في: (2009)